FOLH1 and Familial prostate cancer: Other prostate cancer cell lines were evaluated but found unsuitable for this study: DU-145 and PC-3 lack PSMA expression, PC-3 PIP cells express artificially high levels of PSMA, and LNCaP cells showed poor tolerance to the experimental procedures, resulting in substantial cell loss.